ChengDa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
ChengDa Pharmaceuticals has a total shareholder equity of CN¥2.2B and total debt of CN¥600.0K, which brings its debt-to-equity ratio to 0.03%. Its total assets and total liabilities are CN¥2.4B and CN¥157.6M respectively. ChengDa Pharmaceuticals's EBIT is CN¥36.8M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥1.3B.
Key information
0.03%
Debt to equity ratio
CN¥600.00k
Debt
| Interest coverage ratio | -0.7x |
| Cash | CN¥1.25b |
| Equity | CN¥2.25b |
| Total liabilities | CN¥157.62m |
| Total assets | CN¥2.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301201's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥152.9M).
Long Term Liabilities: 301201's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥4.7M).
Debt to Equity History and Analysis
Debt Level: 301201 has more cash than its total debt.
Reducing Debt: 301201's debt to equity ratio has reduced from 37.9% to 0.03% over the past 5 years.
Debt Coverage: 301201's debt is well covered by operating cash flow (25081.1%).
Interest Coverage: 301201 earns more interest than it pays, so coverage of interest payments is not a concern.